{"date":"2026-06-09","count":45,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7888-2026-06-09-2225-rzgerl","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"22:25:26","subject":"公告本公司成立審計委員會，監察人自然解任","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 22:25，「公告本公司成立審計委員會，監察人自然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-2218-1l26p5c","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"22:18:28","subject":"公告本公司第一屆審計委員會推選召集人","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 22:18，「公告本公司第一屆審計委員會推選召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-2212-7j7htv","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"22:12:09","subject":"公告本公司第一屆審計委員會委員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 22:12，「公告本公司第一屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-2205-1ypmmta","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"22:05:45","subject":"公告本公司董事會推選董事長、副董事長","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 22:05，「公告本公司董事會推選董事長、副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-2152-cxhrnq","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"21:52:47","subject":"公告本公司115年股東常會決議通過解除新任董事及其代表人競業之限制","clause":"第22款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 21:52，「公告本公司115年股東常會決議通過解除新任董事及其代表人競業之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-1913-1mfgnm7","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"19:13:43","subject":"公告本公司115年股東常會改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 19:13，「公告本公司115年股東常會改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-06-09-1904-1jb8ii5","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"19:04:19","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-06-09 19:04，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-06-09-1828-xz10a9","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"18:28:08","subject":"公告本公司新任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-06-09 18:28，「公告本公司新任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-06-09-1827-1szuhi6","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"18:27:32","subject":"本公司法人董事指派代表人","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-06-09 18:27，「本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2026-06-09-1807-lewzru","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"18:07:34","subject":"公告本公司2026年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2026-06-09 18:07，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-06-09-1758-1cccuo4","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"17:58:36","subject":"公告本公司董事長訂定除息基準日","clause":"第14款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-06-09 17:58，「公告本公司董事長訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1757-s0kpz3","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:57:04","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:57，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1756-155ao8v","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:56:29","subject":"公告本公司第三屆薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:56，「公告本公司第三屆薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1756-za3byx","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:56:03","subject":"公告本公司第四屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:56，「公告本公司第四屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1755-1x72eib","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:55:32","subject":"本公司股東常會決議解除新任董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:55，「本公司股東常會決議解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-06-09-1755-1jb8ii5","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"17:55:24","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-06-09 17:55，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1754-pzlnkm","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:54:35","subject":"公告本公司115年股東常會全面改選董事與獨立董事當選名單暨三分之一以上董事發生變動。","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:54，「公告本公司115年股東常會全面改選董事與獨立董事當選名單暨三分之一以上董事發生變動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2026-06-09-1753-1jb8ii5","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"17:53:42","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-06-09 17:53，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-06-09-1738-buv421","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"17:38:03","subject":"代重要子公司SLK-V公告與SLK-M進行簡易合併","clause":"第11款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-06-09 17:38，「代重要子公司SLK-V公告與SLK-M進行簡易合併」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-06-09-1708-m71431","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"17:08:05","subject":"本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-06-09 17:08，「本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-06-09-1655-wnojiv","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"16:55:37","subject":"公告本公司為提高資源配置效益，加速LXP103專案，經董事會決議暫緩子公司LXP109臨床試驗案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-06-09 16:55，「公告本公司為提高資源配置效益，加速LXP103專案，經董事會決議暫緩子公司LXP109臨床試驗案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-06-09-1655-5xp9q1","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"16:55:07","subject":"公告本公司配合會計師事務所內部調整更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-06-09 16:55，「公告本公司配合會計師事務所內部調整更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-06-09-1629-1prvadq","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"16:29:33","subject":"公告本公司一一五年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-06-09 16:29，「公告本公司一一五年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1544-zkkjkj","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:44:12","subject":"公告本公司董事會決議委任永續發展委員會委員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:44，「公告本公司董事會決議委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1543-1eaiuug","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:43:04","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:43，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1541-1fh57gu","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:41:50","subject":"公告本公司審計委員會之委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:41，「公告本公司審計委員會之委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1540-dx1zpf","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:40:22","subject":"公告本公司董事長及副董事長續任","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:40，「公告本公司董事長及副董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1539-19cyjdz","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:39:16","subject":"公告本公司115年股東常會同意解除董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:39，「公告本公司115年股東常會同意解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1538-xvmqkh","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:38:07","subject":"公告本公司董事當選名單(任期屆滿改選)","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:38，「公告本公司董事當選名單(任期屆滿改選)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1536-1g41lqr","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:36:43","subject":"公告本公司薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:36，「公告本公司薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-06-09-1536-1jb8ii5","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-06-09","time":"15:36:36","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-06-09 15:36，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1535-8ysypv","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:35:40","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:35，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1534-1a92q3c","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:34:47","subject":"公告本公司董事會推舉董事長及副董事長","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:34，「公告本公司董事會推舉董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1533-14qlso6","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:33:51","subject":"公告本公司115年股東常會通過解除董事競業禁止案","clause":"第22款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:33，「公告本公司115年股東常會通過解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1532-zhkfod","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:32:55","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:32，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-06-09-1531-1jb8ii5","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:31:51","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-06-09 15:31，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-06-09-1515-1r9zw79","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"15:15:11","subject":"公告本公司與健亞生物科技股份有限公司股份轉換案之股份轉換基準日","clause":"第53款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-06-09 15:15，「公告本公司與健亞生物科技股份有限公司股份轉換案之股份轉換基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-06-09-1515-1jb8ii5","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"15:15:07","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-06-09 15:15，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-06-09-1506-1nbjc38","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-09","time":"15:06:35","subject":"公告本公司庫藏股買回數量達已發行股份總數百分之二","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-06-09 15:06，「公告本公司庫藏股買回數量達已發行股份總數百分之二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1157-1smxj1u","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:57:27","subject":"公告本公司董事會委任第五屆薪資報酬委員會成員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:57，「公告本公司董事會委任第五屆薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1157-19983wl","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:57:01","subject":"公告本公司股東會決議解除新任董事(含獨立董事)競業禁止","clause":"第22款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:57，「公告本公司股東會決議解除新任董事(含獨立董事)競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1155-10qypxo","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:55:49","subject":"公告本公司第三屆審計委員會成員","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:55，「公告本公司第三屆審計委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1155-jfykxi","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:55:15","subject":"公告本公司第六屆董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:55，「公告本公司第六屆董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1154-kfpygl","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:54:21","subject":"公告本公司董事會推選留忠正先生續任董事長","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:54，「公告本公司董事會推選留忠正先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-06-09-1154-jflio5","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-06-09","time":"11:54:01","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-06-09 11:54，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}